Group 4A: HER2+ Breast Cancer; Antibody-drug Conjugates; Brain Metastasis; Clinical Trials; Novel Targets & Therapies
Thursday, June 15
10:00 am – 11:30 am Eastern Time (US/New York)
Scientist: Guilherme Nader Marta, M.D., Ph.D. Candidate
Guilherme Nader Marta received his medical degree from the University of Sao Paulo (Brazil) and completed his oncology residency in the same institution. Since 2021, he has joined Jules Bordet Institute in Belgium as a clinical research fellow, where his time is dedicated to breast cancer research.
He is currently a PhD candidate at the Universite Libre de Bruxelles (ULB) with a research line in biomarkers and breast cancer special histological types, particularly lobular breast cancer.
The results of his research have been presented at international conferences, published in peer-reviewed journals and, in recognition for the high quality of his work, he received a Conquer Cancer Merit Award in 2022 and a Young Investigator Award in 2023.